Evidence map›Paper›PMID 33196947›Full record

ArticleInflammopharmacology2021

Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation.

Tiziana Latronico, Marilena Larocca, Serafina Milella, Anna Fasano, Rocco Rossano, Grazia Maria Liuzzi

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Inflammopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Isothiocyanate-Rich Essential Oil ofPlants (Basel, Switzerland) · 2026
    Article
  2. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
  5. Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease.CNS & neurological disorders drug targets · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tiziana LatronicoDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy. tiziana.latronico@uniba.it.ORCID http://orcid.org/0000-0001-6971-5416
Marilena LaroccaDepartment of Sciences, University of Basilicata, Potenza, Italy.
Serafina MilellaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Anna FasanoDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Rocco RossanoDepartment of Sciences, University of Basilicata, Potenza, Italy.
Grazia Maria LiuzziDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
University of Bari Aldo Moro · ITUniversity of Basilicata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isothiocyanates (ITCs), present as glucosinolate precursors in cruciferous vegetables, have shown anti-inflammatory, antioxidant and anticarcinogenic activities. Here, we compared the effects of three different ITCs on ROS production and on the expression of matrix metalloproteinase (MMP)-2 and -9, which represent important pathogenetic factors of various neurological diseases. Primary cultures of rat astrocytes were activated by LPS and simultaneously treated with different doses of Allyl isothiocyanate (AITC), 2-Phenethyl isothiocyanate (PEITC) and 2-Sulforaphane (SFN). Results showed that SFN and PEITC were able to counteract ROS production induced by H

Indexed as

AnimalsAstrocytesCells, CulturedDisease Models, AnimalDose-Response Relationship, DrugFemaleInflammationIsothiocyanatesMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Neuroprotective AgentsRatsRats, WistarReactive Oxygen SpeciesSulfoxidesallyl isothiocyanateIsothiocyanatesMatrix Metalloproteinase 2Matrix Metalloproteinase 9Mmp2 protein, ratMmp9 protein, ratNeuroprotective Agentsphenethyl isothiocyanateReactive Oxygen SpeciessulforaphaneSulfoxidesAnti-inflammatoryAntioxidantIsothiocyanateMatrix metalloproteinasesNeurodegenerative diseases

Identifiers

PMID33196947
PMCPMC7997826
OpenAlexW3106040583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.